SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to ...

Company Set to Make Migration from Preclinical to Clinical Stage BALTIMORE, MD / ACCESS Newswire / July 17, 2025 / Goldman ...

AstraZeneca’s anselamimab has failed to show any benefit in patients with light chain amyloidosis in two Phase III trials.

Children around the world need sponsors to help them get an education. The Matsiko World Orphan Choir made a stop at Wisner ...